Market Place
Sourcing Support
Biocon Signs Out-Licensing Deal For Semaglutide With Ajanta
23 Dec 2025 //
INDPHARMAPOST
Ajanta Pharma Announces Q1 FY26 Consolidated PAT of Rs. 255.34 Cr
30 Jul 2025 //
INDPHARMAPOST
Ajanta Pharma Ltd spurts 2.5%, up for five straight sessions
03 Feb 2025 //
BUSINESS STD
Ajanta Pharma Ltd slips for fifth straight session
26 Dec 2024 //
BUSINESS STD
Ajanta Pharma Ltd soars 1.25%, up for fifth straight session
22 Nov 2024 //
BUSINESS STD
Ajanta Pharma Ltd gains for third straight session
19 Nov 2024 //
BUSINESS STD
Ajanta Pharma share price zooms 4% as ex-dividend date looms
05 Nov 2024 //
BUSINESS STD
Ajanta Pharma Ltd spurts 2.75%, rises for third straight session
31 Oct 2024 //
BUSINESS STD
Ajanta Pharma posts Q1 FY25 consolidated PAT at Rs. 245.77 Cr
01 Aug 2024 //
INDIANPHARMAPOST
Ajanta Pharma reports 18% growth on net profit in Q1FY25
31 Jul 2024 //
PHARMABIZ
Ajanta Pharma posts Q4 FY24 consolidated PAT at Rs. 202.72 Cr
04 May 2024 //
INDINPHARMAPOST
Ajanta Pharma posts Q2 FY24 consolidated PAT at Rs. 195.30 Cr
01 Nov 2023 //
INDIAN PHARMA POST
Ajanta Pharma looks to expand ops in high-growth Asian, African geographies
02 Jul 2023 //
ECONOMIC TIMES
Ajanta Pharma bags India’s "Best Managed Companies" award
17 Oct 2022 //
INDIANPHARMAPOST
Ajanta Pharma Q2 net profit stood at Rs. 196 crore
30 Oct 2021 //
PHARMABIZ
Ajanta Pharma earmarks Rs 250 crore capex for current fiscal
07 May 2021 //
ECONOMICTIMES
Cadila Healthcare share price hits 52-week high on USFDA nod for cancer drug
08 Apr 2020 //
MONEYCONTROL
Ipca Lab, Ajanta Pharma: Two pharma stocks HDFC Securities is bullish on
03 Mar 2020 //
BUSINESS-STANDARD
Allergan settles Bystolic patent dispute with Ajanta
04 Jan 2020 //
SEEKINGAPLHA
Strides Shasun, Ajanta Pharma pass USFDA`s ranitidine impurity test
06 Nov 2019 //
MONEYCONTROL
After US FDA flags ranitidine, DCGI asks state regulators to get antacid tested
25 Sep 2019 //
LIVEMINT
Hold Ajanta Pharmaceuticals; target of Rs 1060: ICICI Direct
03 May 2019 //
MONEYCONTROL
Ajanta Pharma Q1 net up 12 pc at Rs 106 cr
31 Jul 2018 //
ECONOMIC TIMES
Ajanta Pharma manages small profit growth during Q3
25 Jan 2018 //
PHARMABIZ
Ajanta Pharma: Growth driven by India, US markets
13 Dec 2017 //
BUSINESS-STANDARD
Ajanta Pharma rises 1% on USFDA final nod for Clonidine Hydrochloride tablets
21 Nov 2017 //
MONEYCONTROL
Ajanta Pharma gets USFDA nod for Parkinson`s disease tablet
04 Sep 2017 //
ECONOMIC TIMES
Ajanta Pharma rises 3% on USFDA nod for migraine drug
30 Aug 2017 //
MONEYCONTROL
Sell Ajanta Pharma, target Rs 1,060: Dharmesh Shah
22 Aug 2017 //
ECONOMIC TIMES
Ajanta Pharma focuses on US; plans to file 15 ANDAs in FY18
07 Jul 2017 //
TIMES OF INDIA
Indian drugmakers face squeeze in U.S. healthcare market
17 Mar 2017 //
REUTERS
Ajanta Pharma denies alert from USFDA, says supply is on
25 Jan 2017 //
ECONOMIC TIMES
US FDA actions, DPCO hit sales & profits of top 30 cos in first half of 2016-17
21 Nov 2016 //
PHARMABIZ
Ajanta Pharma Announces the Launch of Amlodipine + Olmesartan Medoxomil Tablets
03 Nov 2016 //
PR NEWSWIRE
Ajanta Pharma Announces the Launch of Almotriptan Malate Tablets
19 Jul 2016 //
PR NEWSWIRE
Ajanta Pharma launches acid reflux drug in US
18 Jul 2016 //
ECONOMIC TIMES
Ajanta Pharma launches anti-dementia drug in US
15 Jun 2016 //
THE ECONOMIC TIMES
Ajanta Pharma gets USFDA nod for migraine pain relief drug
23 May 2016 //
ECONOMIC TIMES
Ajanta Pharma Announces the Launch of Levetiracetam Tablets
24 Mar 2016 //
PR NEWSWIRE
NPPA reverses course, withdraws pricing order
14 Jan 2016 //
TWO FOUR INSIGHT
Drugmakers launch cut-price versions of type 2 diabetes medicine
15 Dec 2015 //
ECONOMIC TIMES
Indian pharma firms gear up for US product launches: Report
08 Dec 2015 //
BUSINESS STANDARD
Ajanta Announces Launch of Montelukast IR and Montelukast Chewable Tablets
03 Dec 2015 //
PR NEWS WIRE
Ajanta Pharma Q2 net up 20% at Rs 100 crore
30 Oct 2015 //
BUSINESS STANDARD
